Publications by authors named "Fnu Tanvir"

Article Synopsis
  • Cannabis-induced pancreatitis (CIP) is becoming more common, especially among younger users, and presents unique challenges in diagnosis due to its symptom overlap with other types of acute pancreatitis.
  • The condition arises from cannabinoids affecting pancreatic receptors, leading to inflammation and dysfunction, which requires careful patient history for accurate diagnosis.
  • Management typically involves supportive care and stopping cannabis use; however, long-term follow-up is needed to prevent chronic pancreatitis, highlighting the importance of further research into its mechanisms and effects on pancreatic health.
View Article and Find Full Text PDF

Arachnoiditis ossificans (AO) is a rare and complex neurological condition characterized by pathological calcification or ossification of the arachnoid membrane. Arachnoiditis ranks as the third most frequent cause of failed back surgery syndrome (FBSS). This narrative review explores the evolving radiological approaches in its diagnosis and monitoring.

View Article and Find Full Text PDF

Gastroesophageal reflux disease (GERD) remains a significant global health concern, with increasing prevalence and a substantial impact on quality of life. This narrative review explores recent advances in our understanding of GERD pathophysiology, diagnosis, and management. The complex interplay of factors contributing to GERD, including lower esophageal sphincter dysfunction, transient sphincter relaxations, and esophageal motility disorders, is discussed.

View Article and Find Full Text PDF

Obesity significantly impacts gut microbial composition, exacerbating metabolic dysfunction and weight gain. Traditional treatment methods often fall short, underscoring the need for innovative approaches. Glucagon-like peptide-1 (GLP-1) agonists have emerged as promising agents in obesity management, demonstrating significant potential in modulating gut microbiota.

View Article and Find Full Text PDF

Cardiovascular diseases (CVDs), including ischemic heart disease and stroke, are the leading cause of mortality worldwide, causing nearly 20 million deaths annually. Traditional therapies, while effective, have not curbed the rising prevalence of CVDs driven by aging populations and lifestyle factors. This review highlights innovative therapeutic strategies that show promise in improving patient outcomes and transforming cardiovascular care.

View Article and Find Full Text PDF